A probable case of tick-borne encephalitis (TBE) acquired in England, July 2019.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Nov 2019
Historique:
entrez: 28 11 2019
pubmed: 28 11 2019
medline: 11 8 2020
Statut: ppublish

Résumé

The United Kingdom (UK) has thus far been considered to be free from tick-borne encephalitis (TBE), yet in July 2019, a German infant developed serologically diagnosed TBE following a tick bite in southern England. This first report of a probable human case together with recent findings of TBE virus in ticks in foci in England suggest that TBE may be acquired in parts of England and should be considered in patients with aetiologically-unexplained neurological manifestations.

Identifiants

pubmed: 31771699
doi: 10.2807/1560-7917.ES.2019.24.47.1900679
pmc: PMC6885749
doi:

Substances chimiques

Immunoglobulin G 0
Immunoglobulin M 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Emerg Infect Dis. 2020 Jan 17;26(1):null
pubmed: 31661056
Brain. 1999 Nov;122 ( Pt 11):2067-78
pubmed: 10545392
J Clin Virol. 2003 Jul;27(2):136-45
pubmed: 12829035
Front Cell Infect Microbiol. 2013 Sep 10;3:48
pubmed: 24058903
Lancet. 2008 May 31;371(9627):1861-71
pubmed: 18514730
Euro Surveill. 2017 Mar 16;22(11):
pubmed: 28333618
J Gen Virol. 2014 May;95(Pt 5):1005-14
pubmed: 24552787
Euro Surveill. 2019 Oct;24(43):null
pubmed: 31662158
Pathogens. 2019 Mar 29;8(2):null
pubmed: 30934855
Euro Surveill. 2019 Nov;24(47):null
pubmed: 31771701
Euro Surveill. 2016 Aug 18;21(33):
pubmed: 27562931

Auteurs

Teresa M Kreusch (TM)

Immunization Unit, Robert Koch Institute, Berlin, Germany.

Maya Holding (M)

Virology and Pathogenesis Group, National Infection Service, Public Health England, Porton Down, United Kingdom.
NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.

Roger Hewson (R)

Virology and Pathogenesis Group, National Infection Service, Public Health England, Porton Down, United Kingdom.
NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.

Thomas Harder (T)

Immunization Unit, Robert Koch Institute, Berlin, Germany.

Jolyon M Medlock (JM)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.
Medical Entomology Group, Emergency Response Department, Public Health England, Porton Down, United Kingdom.

Kayleigh M Hansford (KM)

Medical Entomology Group, Emergency Response Department, Public Health England, Porton Down, United Kingdom.

Stuart Dowall (S)

Virology and Pathogenesis Group, National Infection Service, Public Health England, Porton Down, United Kingdom.
NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.

Amanda Semper (A)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.
Tuberculosis, Acute Respiratory, Gastrointestinal, Emerging/Zoonotic Infections and Travel Health Division, National Infection Service, Public Health England, London, United Kingdom.

Tim Brooks (T)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.
Tuberculosis, Acute Respiratory, Gastrointestinal, Emerging/Zoonotic Infections and Travel Health Division, National Infection Service, Public Health England, London, United Kingdom.

Amanda Walsh (A)

Tuberculosis, Acute Respiratory, Gastrointestinal, Emerging/Zoonotic Infections and Travel Health Division, National Infection Service, Public Health England, London, United Kingdom.

Katherine Russell (K)

Tuberculosis, Acute Respiratory, Gastrointestinal, Emerging/Zoonotic Infections and Travel Health Division, National Infection Service, Public Health England, London, United Kingdom.

Ole Wichmann (O)

Immunization Unit, Robert Koch Institute, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH